Kidney nerve procedure tested for stubborn high blood pressure
NCT ID NCT05818813
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at the long-term safety and effects of a procedure called renal denervation in 9 patients with resistant hypertension (high blood pressure that doesn't respond to multiple medications). The procedure uses a device to disrupt certain nerves in the kidney arteries, aiming to lower blood pressure. Researchers measured blood pressure and artery function before and 6 months after the procedure. The study was terminated early, so results are limited.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Renal denervation (a procedure using a device to disrupt nerves in the kidney arteries)
- What this could lead to
- If successful, this could point toward a long-term treatment option for patients with hard-to-control high blood pressure.
- What could go wrong
- This was a very small, terminated study with only 9 participants, so results are limited and may not apply to others. The procedure carries risks like artery damage or bleeding.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
9 people
The number who actually took part.
- Started
-
Apr 2021
- Finished
-
Apr 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
People with resistant hypertension and no contraindication to renal denervation.
- Ages
-
18 years and older
- Sex
-
Anyone
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Systolic blood pressure \>160mmHg despite 3 antihypertensive agents * eGFR \>45 Exclusion Criteria: * Secondary causes of hypertension * Prior renal artery intervention * Renal insufficiency * Significant stenotic valvular heart disease * Myocardial infarction, unstable angina or stroke within the preceding 6 months
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Hypertension are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hammersmith Hospital
London, Middlesex, W12 0HS, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can pressing six points on the body help older adults sleep?
- Can AI-Tailored heat warnings shield chronic disease patients from dangerous temperatures?
- Could a quieter, automated blood pressure check help more people control hypertension?
- Can a phone call boost confidence in managing high blood pressure?
- Smart pillbox aims to keep patients on track
- Wristband vs. cuff: can a cuffless device match 24-Hour blood pressure monitoring?